There is currently no drug for treating non-alcoholic fatty liver disease, which affects many people with type 2 diabetes and which can result in other serious liver diseases.
Hepatocellular carcinoma (HCC), the most common type of liver cancer, can place a significant financial burden on patients, according to an analysis led by a researcher at UT Southwestern Medical Center.
Dr Ajay Duseja, Professor and Head of the Hepatology Department, has been conferred with the prestigious ISG Dr CM Habibullah Oration for 2023 for his research work in the field of non-alcoholic fatty liver disease (NAFLD).The